Startups

Director, Field Operations

Definium Therapeutics · Remote · Remote

← All jobs
About Definium Therapeutics

Definium Therapeutics develops psychedelic-based therapeutics for psychiatric and neurological disorders. Backed by North Carolina Biotechnology Center.

About the role

Together we are moving psychiatry forward—beyond better, into a boundless future. Join us! Found on 1752vc Careers, the job board for startup and VC roles.

What they're looking for

  • Minimum bachelor’s degree required, degree in business, life sciences, analytics, healthcare, or a related field preferred
  • Minimum 10 years of related work experience required
  • Progressive pharmaceutical, biotech, or life sciences experience in commercial operations, sales operations, or field force effectiveness
  • Pre-launch or launch execution experience, ideally in specialty or complex therapeutics
  • Ability to translate strategy into executable processes, system requirements, controls, and measurable operating outcomes
  • Strong cross-functional leadership, vendor management, communication, analytical judgment, and project management skills
More about this role

Definium Therapeutics is a late-stage clinical biopharmaceutical company and our mission is to forge a new era of psychiatry by applying scientific rigor to psychedelics, with the goal of developing accessible treatments that unlock healing at scale.

Our lead product candidate, lysergide tartrate (our proprietary orally disintegrating tablet form of lysergide (LSD) D-tartrate), represents a highly differentiated, potential best-in-class opportunity for patients suffering from generalized anxiety, major depressive disorder, and posttraumatic stress disorder. Our early stage pipeline includes DT402, the R-enantiomer of MDMA and is under development to target the core symptoms of autism spectrum disorder (ASD), specifically addressing social communication challenges.

Guided by the recognition that patients deserve more than better, Definium is relentlessly advancing a new generation of therapeutics intended to address the underlying causes of psychiatric and neurological disorders. By turning evidence into impact, Definium aims to change the trajectory of today’s mental health care crisis and enable a healthier future. Headquartered in New York, Definium Therapeutics trades on Nasdaq...

Read the full posting on Definium Therapeutics's site ↗

Commercial

Build your edge while you search

Free tools for founders and investors, plus VC Unfiltered, our take on startups, venture and the people who build them.